Celldex Therapeutics (CLDX) Shares Outstanding (Entity) (2010 - 2026)
Celldex Therapeutics (CLDX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 139.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.54 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 214.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 113.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 575.47 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.73 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | 78.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78.50 Mn |
| Mar 31, 2026 | 66.57 Mn |
| Dec 31, 2025 | 66.55 Mn |
| Sep 30, 2025 | 66,420.00 |
| Jun 30, 2025 | 66,392.00 |
| Mar 31, 2025 | 66,383.00 |
| Dec 31, 2024 | 64,395.00 |
| Sep 30, 2024 | 66,294.00 |
| Jun 30, 2024 | 66,019.00 |
| Mar 31, 2024 | 58,871.00 |
| Dec 31, 2023 | 48,449.00 |
| Sep 30, 2023 | 47,261.00 |
| Jun 30, 2023 | 47,253.00 |
| Mar 31, 2023 | 47,214.00 |
| Dec 31, 2022 | 46,888.00 |
| Sep 30, 2022 | 47.10 Mn |
| Jun 30, 2022 | 46.76 Mn |
| Mar 31, 2022 | 46.75 Mn |
| Dec 31, 2021 | 42,870.00 |
| Sep 30, 2021 | 46.66 Mn |